Centrexion Therapeutics
MA - BostonBiotechnology
Focus: Centrexion Therapeutics is a Boston-based biotechnology company focused on developing novel pain therapies, primarily targeting neurological indications including osteoarthritis, neuropathies, and localized pain conditions.
Profile data last refreshed 2d ago · AI intelligence enriched 2w ago
Open Jobs
0
About Centrexion Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Centrexion Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthStrong
Pipeline
Late-stage
3 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Oral dose CNTX-6016 or oral dose Placebo
Painful Diabetic NeuropathyClinical Trials (1)
NCT04857957Safety, Tolerability & Pharmacokinetics Study of CNTX-6016 in Healthy Subjects and Subjects With PDN
Phase 1Help build intelligence for Centrexion Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.